Morinaga Milk Industry has patented a composition using Bifidobacterium bacterium to promote the secretion of FGF21, modulating palatability in subjects. The method aims to reduce unbalanced diets, encourage variety in food intake, and adjust taste preferences. GlobalData’s report on Morinaga Milk Industry gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Premium Insights Morinaga Milk Industry Co Ltd - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Morinaga Milk Industry, Lactobacilli-based drug compositions was a key innovation area identified from patents. Morinaga Milk Industry's grant share as of January 2024 was 30%. Grant share is based on the ratio of number of grants to total number of patents.

A recently granted patent (Publication Number: US11857579B2) discloses a method for modulating palatability in a subject by administering a specific strain of Bifidobacterium bacterium, Bifidobacterium breve M-16V (NITE BP-02622). The modulation of palatability is achieved through the promotion of the secretion of FGF21 in the subject. This method aims to reduce unbalanced types of diet, promote a wide variety of food intake without faddiness, and adjust the sense of taste. The Bifidobacterium bacterium can be administered in the form of a food or drink composition, or a pharmaceutical composition, providing flexibility in its application.

Furthermore, the patent also covers methods for maintaining body temperature and improving sensitivity to cold in a subject by administering the same strain of Bifidobacterium bacterium, Bifidobacterium breve M-16V (NITE BP-02622). In both cases, the maintenance of body temperature and improvement in sensitivity to cold are achieved through the promotion of FGF21 secretion in the subject. Similar to the method for modulating palatability, the Bifidobacterium bacterium can be included in food or drink compositions, as well as pharmaceutical compositions, offering various options for administration. These methods provide innovative approaches to address issues related to palatability, body temperature maintenance, and sensitivity to cold through the modulation of specific biological pathways.

To know more about GlobalData’s detailed insights on Morinaga Milk Industry, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.